Avaya Holdings Corp.: Nasdaq/NYSE listing notice — Avaya receives NYSE non-compliance notice for stock price below $1.00; six-month cure period

Avaya Holdings Corp.

NYSE notified Avaya on Dec 29, 2022 that avg closing price of common stock was below $1.00 over 30 consecutive trading days.
Avaya intends to notify NYSE of intent to cure within six-month period; stock continues trading on NYSE during cure period.
Failure to regain compliance could lead to suspension and delisting; company also cites risks addressing convertible notes maturing June 2023 and going concern.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Avaya Holdings Corp. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

December 29, 2022, Avaya Holdings Corp. (the “Company”) was notified (the “NYSE Notice”) by the New York Stock Exchange (“NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock, par value $0.01 per share (the “Common Stock”), was less than $1.00 over a consecutive 30 trading-day period. The NYSE Notice does not result in the immediate delisting of the Common Stock from the NYSE. In accordance with the NYSE rules, the Company intends to notify the NYSE of its intent to cure the stock price defici

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001418100-22-000121

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.